Respiratory Oscillometry Norms for Polish Children and Adolescent. (OSCILLONiCA-PL)

October 2, 2025 updated by: Eliza Wasilewska, Medical University of Gdansk

Respiratory Oscillometry - Establishing Reference Values in Polish Children and Adolescents Aged 3-18 Years (OSCILLONiCA-PL-Kids)

This study aims to establish normative values for respiratory oscillometry in the Polish pediatric population. It is designed as a multicentre, population-based, prospective cohort study including children and adolescents aged 3-18 years. The results will provide reference standards for respiratory oscillometry that may support the diagnosis and monitoring of respiratory diseases in clinical practice and research.

Study Overview

Status

Completed

Detailed Description

OSCILLONiCA-PL-Kids is a multicentre, observational, cross-sectional study designed to establish normative reference values for respiratory oscillometry (IOS) in healthy Polish children and adolescents aged 3-18 years. The study is coordinated by the Polish Society of Pediatric Pulmonology and conducted in 12 pediatric centers across Poland between 2023 and 2025.

Standardized Jaeger oscillometry systems (ERS-validated) are used across all sites, following harmonized operating procedures. All investigators and technicians undergo centralized training and certification, with periodic audits and refresher sessions to ensure procedural consistency and data quality. Measurements are performed during tidal breathing with cheek support and a nose clip, recording at least three technically acceptable trials per participant. Parameters include resistance (Rrs) and reactance (Xrs) at 5, 10, and 20 Hz, resonance frequency (Fres), and area of reactance (AX).

Anthropometric data (height, weight, age, sex) are collected simultaneously to allow modeling of predicted values. Data integrity is verified using automated quality-control algorithms. Reference equations for oscillometric parameters will be derived using generalized additive models for location, scale, and shape (GAMLSS, LMS method). Model performance will be evaluated using the Schwarz Bayesian Criterion, with sensitivity analyses assessing robustness to borderline cases and environmental exposures.

Raw measurement data, as well as derived parameters (means, standard deviations, percentiles, and z-scores), will be used to generate normative reference values and percentile charts stratified by age, height, and sex.

Quality assurance: Data collection and management follow standardized operating procedures (SOPs) approved by the coordinating center. Each site conducts internal data validation prior to upload, and periodic cross-site audits are performed to ensure compliance and consistency. Automatic range and logic checks are implemented in the database to flag out-of-range or inconsistent entries.

Missing data plan: Incomplete or invalid recordings will be excluded from normative modeling. Sensitivity analyses will evaluate the impact of missing data on reference equations. Imputation will not be used for normative dataset derivation.

The study adheres to ERS Technical Standards for Oscillometry (2020) and complies with Good Clinical Practice for observational research. The resulting reference equations and percentile charts will provide validated normative standards for pediatric oscillometry in Poland and support future international harmonization efforts.

Study Type

Observational

Enrollment (Actual)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gdańsk
      • Gdansk, Gdańsk, Poland, 80-211
        • Medical University of Gdansk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy Polish children and adolescents aged 3 to 18 years. Participants are recruited from schools, kindergartens, and pediatric outpatient clinics across 12 centers in Poland. Only individuals without chronic respiratory diseases or recent respiratory infections are eligible.

Description

Inclusion Criteria:1. Age between 3 and 18 years. 2. Caucasian race (Born and residing in Poland). 3. Absence of chronic respiratory disease or acute respiratory symptoms at the time of testing.

4. Written informed consent from a parent/legal guardian (for participants <16 years) or from the participant if ≥16 years.

-

Exclusion Criteria:1. History of chronic lung disease (e.g., asthma, cystic fibrosis, bronchopulmonary dysplasia, interstitial lung disease).

2. Acute respiratory infection within 4 weeks before testing. 3. Severe chronic comorbidities (e.g., congenital heart disease, neuromuscular disorders).

4. Chest deformation 5. Inability to perform oscillometry according to ERS standards.

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reference values and z-score distributions for respiratory oscillometry parameters (Rrs, Xrs, Fres, AX) in healthy Polish children and adolescents
Time Frame: Single assessment at baseline (during one study visit).

Quantitative reference data for respiratory oscillometry parameters - respiratory resistance (Rrs) and reactance (Xrs) at 5, 10, and 20 Hz, resonance frequency (Fres), and area of reactance (AX) - measured using impulse oscillometry (IOS) in healthy children and adolescents aged 3-18 years.

Results will be summarized as mean (Units of Measure:

Rrs, Xrs: kPa·s·L-¹; Fres: Hz; AX: kPa·L-¹); standard deviation (SD), percentiles, and z-score distributions stratified by age, height, and sex.

Single assessment at baseline (during one study visit).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prediction equations and z-score reference models for oscillometric parameters (Rrs, Xrs, Fres, AX)
Time Frame: At baseline (single study visit).

Regression models describing the relationship between oscillometric parameters (Rrs, Xrs, Fres, AX) and anthropometric predictors (age, height, weight, sex). Models will be developed using the Generalized Additive Models for Location, Scale, and Shape (GAMLSS; LMS method).

Predicted means, SDs, and z-score equations will be reported, together with model coefficients, standard errors, and model fit indices (Schwarz Bayesian Criterion). Units of Measure: Model coefficients (unitless); Rrs, Xrs: kPa·s·L-¹; Fres: Hz; AX: kPa·L-¹; z-scores: dimensionless

At baseline (single study visit).
Variability of respiratory oscillometry parameters (Rrs, Xrs, Fres, AX) across pediatric age groups
Time Frame: At baseline (single study visit).

Mean and standard deviation of oscillometry parameters - respiratory resistance (Rrs, kPa·s·L-¹), reactance (Xrs, kPa·s·L-¹), resonance frequency (Fres, Hz), and area of reactance (AX, kPa·L-¹) - compared across three predefined pediatric age groups: preschool (3-5 years), school-aged (6-12 years), and adolescents (13-18 years).

All parameters will also be expressed as z-scores (dimensionless) for standardized inter-group comparison.Units of Measure: Rrs, Xrs: kPa·s·L-¹; Fres: Hz; AX: kPa·L-¹; z-scores: dimensionless.

At baseline (single study visit).
Z-score distributions for oscillometry parameters across Polish and international pediatric cohorts
Time Frame: Up to 24 months after completion of data collection (estimated by December 2026).

Z-score distributions for respiratory resistance (Rrs), reactance (Xrs), resonance frequency (Fres), and area of reactance (AX) derived from the OSCILLONiCA-KIDS dataset and published international reference datasets (Austria).

Differences between cohorts will be summarized as mean z-score differences and limits of agreement.

Up to 24 months after completion of data collection (estimated by December 2026).
Nomograms and percentile charts for clinical use
Time Frame: Through study completion, approximately 36 months after study start (January 2023 - December 2025).
Nomograms and percentile charts illustrating predicted oscillometry parameters (Rrs, Xrs, Fres, AX) across age, height, and sex categories will be created to support clinical interpretation. Each chart will include mean, standard deviation (SD), percentiles (5th, 25th, 50th, 75th, 95th), and corresponding z-score ranges.Units of Measure: Rrs, Xrs: kPa·s·L-¹; Fres: Hz; AX: kPa·L-¹; z-scores: dimensionless
Through study completion, approximately 36 months after study start (January 2023 - December 2025).
De-identified reference dataset of pediatric oscillometry measurements
Time Frame: Through study completion, approximately 36 months after study start (January 2023 - December 2025).
A de-identified dataset containing oscillometry and anthropometric data (age, height, weight, sex, Rrs, Xrs, Fres, AX) will be compiled for research use and potential integration into international reference initiatives (e.g., Global Lung Function Initiative). Dataset records will be reported as counts of included participants and data completeness metrics. Units of Measure: Number of data records (n); data completeness (%)
Through study completion, approximately 36 months after study start (January 2023 - December 2025).
Quality and performance indicators of school-based oscillometry testing
Time Frame: Throughout data collection, approximately January 2023 - June 2025.

Proportion of technically acceptable recordings, coefficient of variation (CoV) between repeated trials, and proportion of children successfully completing valid measurements during school-based testing sessions. Units of Measure:

Percentage of valid recordings (%); coefficient of variation (%)

Throughout data collection, approximately January 2023 - June 2025.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2023

Primary Completion (Actual)

July 30, 2025

Study Completion (Actual)

July 30, 2025

Study Registration Dates

First Submitted

September 22, 2025

First Submitted That Met QC Criteria

October 2, 2025

First Posted (Estimated)

October 6, 2025

Study Record Updates

Last Update Posted (Estimated)

October 6, 2025

Last Update Submitted That Met QC Criteria

October 2, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The study team will consider sharing de-identified individual participant data after publication of the primary results, depending on institutional policies and ethical approval.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Subscribe